Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Conmed Narrows FY2025 Adj EPS Guidance from $4.40-$4.55 to $4.48-$4.53 vs $4.47 Est; Narrows FY2025 Sales Guidance from $1.356B-$1.378B to $1.365B-$1.372B vs $1.368B Est

Author: Benzinga Newsdesk | November 05, 2025 04:29pm
Conmed (NYSE:CNMD) narrows FY2025 Adj EPS guidance from $4.40-$4.55 to $4.48-$4.53 vs $4.47 analyst estimate. Narrows FY2025 sales outlook from $1.356 billion-$1.378 billion to $1.365 billion-$1.372 billion vs $1.368 billion estimate.

Posted In: CNMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist